The Current Ratio as of November 2024 (TTM) for Processa Pharmaceuticals, Inc. (PCSA) is 3.97

According to Processa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.97. This represents a change of -39.40% compared to the average of 6.55 of the last 4 quarters.

Processa Pharmaceuticals, Inc. (PCSA) Historical Current Ratio (quarterly & annually)

How has PCSA Current Ratio performed in the past?

The mean historical Current Ratio of Processa Pharmaceuticals, Inc. over the last ten years is 5.39. The current 3.97 Current Ratio has changed 7.27% with respect to the historical average. Over the past ten years (40 quarters), PCSA's Current Ratio was at its highest in in the March 2021 quarter at 22.40. The Current Ratio was at its lowest in in the March 2017 quarter at 0.00.

Processa Pharmaceuticals, Inc. (PCSA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Processa Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Processa Pharmaceuticals, Inc. (PCSA) Average Current Ratio

How has PCSA Current Ratio performed in the past?

The current Current Ratio of Processa Pharmaceuticals, Inc. (PCSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Processa Pharmaceuticals, Inc. (PCSA) Current Ratio vs. Peers

How is PCSA’s Current Ratio compared to its peers?

Processa Pharmaceuticals, Inc.’s Current Ratio is greater than Alpha Cognition Inc. (1.50), greater than Eupraxia Pharmaceuticals Inc. (1.95), greater than Acurx Pharmaceuticals, Inc. (1.74), less than Fennec Pharmaceuticals Inc. (7.80), greater than Comera Life Sciences Holdings, Inc. (0.90), greater than SAB Biotherapeutics, Inc. (3.69), less than Fresh Tracks Therapeutics, Inc. (6.98), less than Third Harmonic Bio, Inc. (42.50), less than Eliem Therapeutics, Inc. (60.41), less than Inhibrx Biosciences, Inc. (4.70), less than Merrimack Pharmaceuticals, Inc. (10.78), less than Celcuity Inc. (10.36), less than Enliven Therapeutics, Inc. (17.44), less than AN2 Therapeutics, Inc. (9.75), greater than Miromatrix Medical Inc. (3.46), greater than Inhibikase Therapeutics, Inc. (0.85), less than PMV Pharmaceuticals, Inc. (13.98), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Akari Therapeutics, Plc (0.29), greater than Armata Pharmaceuticals, Inc. (0.19), greater than Scopus BioPharma Inc. (0.05),

Build a custom stock screener for Processa Pharmaceuticals, Inc. (PCSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Processa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Processa Pharmaceuticals, Inc. (PCSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Processa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.